Circulating Nucleic Acids and Circulating Rare Cells: Liquid Biopsy for Early Cancer Detection

Home
|
Posters
|

Training Courses

|
Media
|

Keynote Speakers

J. Carl Barrett Vice President, Translational Sciences Oncology, AstraZeneca	George Calin Professor and The Alan M. Gewirtz Leukemia & Lymphoma Society Scholar, University of Texas MD Anderson Cancer Center	Bob Carter Professor and Chief of Neurosurgery, Massachusetts General Hospital, Harvard Medical School	Daniel Chiu A. Bruce Montgomery Professor of Chemistry, University of Washington	Anindya Dutta Harry F. Byrd Professor and Chair of Biochemistry and Molecular Genetics and Professor of Pathology, University of Virginia School of Medicine	Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute
Walter Koch Vice President, Roche Molecular Systems	Lucia Languino Professor of Cancer Biology, Thomas Jefferson University	Cheng-Ho Jimmy Lin Chief Scientific Officer, Oncology, Natera	Y. Peng Loh Chief and Senior Investigator, Section on Cellular Neurobiology, Eunice Kennedy Shriver National Institute of Child health and Human Development, National Institutes of Health (NIH)	Jan Lötvall Professor Krefting Research Centre, University of Gothenburg, Chief Scientist, Codiak BioSciences; Founding President of ISEV	Mike Makrigiorgos Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School
Balaji Panchapakesan Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)	Steven Pirie-Shepherd Director, Pfizer	Peter Quesenberry Professor of Medicine, The Warren Alpert Medical School of Brown University	Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas	Shannon Stott Assistant Professor, Massachusetts General Hospital & Harvard Medical School	David Wong Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles

Overview

Select Biosciences Fifth Annual Circulating Biomarkers World Congress 2018 brings together the most up-to-date technologies and advances in this expanding and evolving field. Our coverage in this conference track focuses on the various classes of circulating nucleic acid biomarkers:

Circulating Nucleic Acids: Circulating Cell-Free DNA (cfDNA)
Circulating RNAs such as microRNAs in Biofluids

This conference features speakers from academia as well as industry addressing the following topic areas:

Technologies for Isolation and Characterization from Various Biofluids
Role in Cancer and Various Other Disease Classes (such as Cardiovascular Disease, CNS Disease and Beyond)
Biomarker Potential for Diagnostics Development

Registered delegates receive access to the co-located concurrent conference tracks, the co-located exhibit hall featuring companies providing tools and technologies address the circulating biomarkers field, as well as round-table discussions facilitating networking in specific topic areas.

Agenda Topics

Circulating microRNAs, Other Classes of Circulating RNAs from Biofluids
Circulating Nucleic Acids and Circulating Tumor Cells (CTCs): Circulating Biomarkers for Liquid Biopsy Development
Circulating Nucleic Acids in Various Disease Classes

Cancer
Cardiovascular Disease
CNS and Neurodegenerative Diseases
Pregnancy and Reproductive Health

Circulating-Free DNA/Cell-Free DNA (cfDNA)
Liquid Biopsies for Early Cancer Detection

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Chung- Er Huang, Assistant Professor, National Chiao Tung University; Managing Director, CytoAurora Biotechnologies, Inc.
Allison Welsh, Associate Director, Liquid Biopsy Development, Foundation Medicine
Abhijit Patel, Associate Professor, Yale University School of Medicine
Frank Slack, Director, Institute for RNA Medicine, Beth Israel Deaconess Medical Center Cancer Center/Harvard Medical School
Taylor Jensen, Director, Research and Development, Sequenom (a LabCorp Company)
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
John Castle, Executive Director, Vaccine Research and Translational Medicine, Agenus Switzerland Inc.
Dana Al Sulaiman, Postgraduate Researcher, Imperial College London
Cha-Mei Tang, President and CEO, Creatv MicroTech
Peter Benn, Professor Emeritus, Department of Genetics and Genome Sciences, University of Connecticut Health Center
Michael Graner, Professor, Dept of Neurosurgery, University of Colorado Anschutz School of Medicine
Qing Kang, Senior Scientist, Translational Medicine, Syros Pharmaceuticals, Inc.
Ryan Dittamore, Vice President, Translational Research and Clinical Affairs, Epic Sciences

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking